- Home
- FUSE vs IINN Comparison
FUSE vs IINN Comparison
Compare FUSE & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FUSE | IINN |
|---|---|---|
| Founded | 2013 | 2018 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.2M | 35.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FUSE | IINN |
|---|---|---|
| Price | $1.39 | $0.57 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | 105.8K | ★ 193.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $9,715.95 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.23 | $0.40 |
| 52 Week High | $3.67 | $1.65 |
Technical Indicators
Market Signals| Indicator | FUSE | IINN |
|---|---|---|
| Relative Strength Index (RSI) | 45.35 | 36.01 |
| Support Level | $1.23 | $0.55 |
| Resistance Level | $2.03 | $0.84 |
| Average True Range (ATR) | 0.11 | 0.03 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 53.52 | 24.62 |
Price Performance
Historical ComparisonAbout FUSE Fusemachines Inc.
Fusemachines Inc is a provider of enterprise AI products and solutions. The company provides good quality AI education in underserved communities and helping organizations achieve their full potential with AI. The products of the company include AI Studio, Answer Gen, GenAI Engines, and others.
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.